Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

6. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Elsevier; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 9, 2024.
  2. Acarbose tablets (Acarbose) package insert. Hikma Pharmaceuticals USA, Inc., July 2024.
  3. Miglitol tablets package insert. Proficient Rx LP., April 2022.
  4. Metformin Hydrochloride tablets package insert. Chartwell RX, LLC., October 2023.
  5. Metformin extended-release tablets package insert. Lupin Pharmaceuticals, Inc., October 2023.
  6. Metformin extended-release tablets (Glumetza) package insert. Santarus, Inc., March 2024.
  7. Metformin oral solution package insert. Saptalis Pharmaceuticals, LLC., August 2024.
  8. Colesevelam tablets and packets for oral suspension (Welchol) package insert. Cosette Pharmaceuticals, Inc., September 2022.
  9. Alogliptin tablets (Nesina) package insert. Takeda Pharmaceuticals America, Inc., July 2023.
  10. Linagliptin tablets (Tradjenta) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., June 2023.
  11. Saxagliptin tablets package insert. Aurobindo Pharma Limited., January 2024.
  12. Sitagliptin tablets (Januvia) package insert. Merck & Co., Inc., July 2023.
  13. Bromocriptine tablets (Cycloset) package insert. Avvisto Therapeutics, LLC., May 2024.
  14. Semaglutide (Rybelsus) tablets package insert. Novo Nordisk, January 2024.
  15. Nateglinide tablets package insert. Actavis Pharma, Inc., July 2023.
  16. Repaglinide tablets package insert. Aurobindo Pharma Limited, December 2022.
  17. Canagliflozin tablets (Invokana) package insert. Janssen Pharmaceuticals, Inc., September 2024. 
  18. Dapagliflozin tablets (Farxiga) package insert. AstraZeneca, June 2024.
  19. Dapagliflozin tablets package insert. Prasco, LLC., June 2024.
  20. Empagliflozin tablets (Jardiance) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., September 2023.
  21. Ertugliflozin tablets (Steglatro) package insert. Merck Sharp & Dohme, LLC., June 2024.
  22. Sotagliflozin tablets (Inpefa) package insert. Lexicon Pharmaceuticals, Inc., January 2024.
  23. Glimepiride tablets package insert. Aurobindo Pharma Limited., November 2023.
  24. Glipizide tablets package insert. Actavis Pharma, Inc., December 2023.
  25. Glipizide tablets package insert. TruPharma, LLC., October 2023.
  26. Glipizide XL extended-release tablets (Glucotrol XL) package insert. Roerig, August 2023.
  27. Glyburide tablets package insert. Chartwell RX, LLC., May 2023.
  28. Glyburide tablets (Glynase) package insert. Pharmacia and Upjohn Company, LLC., October 2017.
  29. Pioglitazone tablets (Actos) package insert. Takeda Pharmaceuticals North America, Inc., October 2022.
  30. Alogliptin/metformin hydrochloride tablets (Kazano) package insert. Takeda Pharmaceuticals America, Inc., July 2023.
  31. Alogliptin/pioglitazone hydrochloride tablets (Oseni) package insert. Takeda Pharmaceuticals America, Inc., June 2024.
  32. Canagliflozin/metformin tablets (Invokamet) and canagliflozin/metformin extended-release tablets (Invokamet XR) package insert. Janssen Pharmaceuticals, Inc., August 2024.
  33. Dapagliflozin/metformin hydrochloride extended-release tablets (Xigduo XR) package insert. AstraZeneca Pharmaceuticals LP., June 2024.
  34. Dapagliflozin/saxagliptin tablets (Qtern) package insert. AstraZeneca Pharmaceuticals LP., September 2023.
  35. Empagliflozin/linagliptin tablets (Glyxambi) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., October 2023.
  36. Empagliflozin/metformin hydrochloride tablets (Synjardy) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., October 2023.
  37. Empagliflozin/metformin hydrochloride extended-release tablets (Synjardy XR) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., October 2023.
  38. Empagliflozin/linagliptin/metformin hydrochloride extended-release tablets (Trijardy XR) package insert. Boehringer Ingelheim Pharmaceuticals, Inc., October 2023.
  39. Ertugliflozin/metformin hydrochloride tablets (Segluromet) package insert. Merck & Co., Inc., June 2024.
  40. Ertugliflozin/sitagliptin phosphate tablets (Steglujan) package insert. Merck Sharp & Dohme, LLC., June 2024.
  41. Glipizide/metformin hydrochloride tablets package insert. Chartwell RX, LLC., August 2023.
  42. Glyburide/metformin hydrochloride tablets package insert. Aurobindo Pharma Limited., May 2024.
  43. Linagliptin/metformin hydrochloride tablets (Jentadueto) package insert.  Boehringer Ingelheim Pharmaceuticals, Inc., June 2023.
  44. Linagliptin/metformin hydrochloride extended-release tablets (Jentadueto XR) package insert.  Boehringer Ingelheim Pharmaceuticals, Inc., June 2023.
  45. Glimepiride/pioglitazone tablets (Duetact) package insert. Takeda Pharmaceuticals America, Inc., October 2022.
  46. Metformin hydrochloride/pioglitazone hydrochloride tablets (Actoplus Met) package insert. Takeda Pharmaceuticals America, Inc., December 2021.
  47. Pioglitazone/ metformin film coated tablets package insert. Aurobindo Pharma Limited. August 2024.
  48. Saxagliptin/metformin hydrochloride extended-release tablet (Kombiglyze XR) package insert. AstraZeneca Pharmaceuticals LP., October 2019.
  49. Sitagliptin/metformin hydrochloride (Janumet) package insert. Merck & Co., Inc., August 2024.
  50. Sitagliptin/metformin extended-release tablets (Janumet XR) package insert. Merck & Co., Inc., August 2023.
  51. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes -2024. Diabetes Care. 2024;47(Suppl. 1):S158–S178.
  52. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022 Nov;102(5S):S1-S127.